1. Home
  2. SLNG vs ALDX Comparison

SLNG vs ALDX Comparison

Compare SLNG & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$5.00

Market Cap

97.4M

Sector

Utilities

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$0.93

Market Cap

88.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
ALDX
Founded
2013
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.4M
88.1M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
SLNG
ALDX
Price
$5.00
$0.93
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $6.60
AVG Volume (30 Days)
20.8K
★ 950.4K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 2400.00
40.43
EPS
★ N/A
N/A
Revenue
★ $68,245,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$70.23
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.21
$1.07
52 Week High
$7.07
$5.93

Technical Indicators

Market Signals
Indicator
SLNG
ALDX
Relative Strength Index (RSI) 46.98 31.33
Support Level $4.79 N/A
Resistance Level $5.52 $1.58
Average True Range (ATR) 0.27 0.11
MACD -0.05 -0.02
Stochastic Oscillator 37.09 5.00

Price Performance

Historical Comparison
SLNG
ALDX

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. The company has a geographical presence in the United States and Mexico.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: